Journal of Drugs in Dermatology

View more issues:

Articles in May-June, 2005 issue of Journal of Drugs in Dermatology

• A chart review of patients with early stage mycosis fungoides treated with psoralen plus UVA
  by Jennifer Soung
• Oracea enters Phase III clinical trials
• Daptomycin in the treatment of patients with renal insufficiency and complicated skin and skin structure infections
• Generic 750 mg levofloxacin for bacterial infections in adults
• Photodynamic therapy using silicon phthalocyanine 4 in treating patients with actinic keratosis, Bowen's disease, skin cancer, or stage I or stage II mycosis fungoides
• Mechanism-based treatment of acne vulgaris: the value of combination therapy
  by Guy Webster
• Basal cell carcinoma of the areola in a man
  by Keyvan Nouri
• No compensatory sweating after botulinum toxin treatment of palmar hyperhidrosis
• New indication for Smoothbeam diode laser
• The acquisition of blood and skin samples from normal volunteers to support research activities on dermatologic diseases
• Cancer risk in carriers of the gene for xeroderma pigmentosum
• Clinical, laboratory, and epidemiologic characterization of individuals and families at high risk of melanoma
• A letter from the Editor-in-Chief
  by Perry Robbins
• A randomized controlled clinical trial assessing the effect of betamethasone valerate 0.12% foam on the short-term treatment of stasis dermatitis
  by Stefan C. Weiss
• Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment
• Linezolid in the treatment of complicated skin and soft tissue due to methicillin-resistant staphylococcus aureus
• An observational study of the use and safety of Raptiva® during pregnancy
• Rosacea, light, and phototherapy
  by Melvin Lee
• Focus on: herpes acquisition and transmission
  by Craig G. Burkhart
• Photodynamic therapy in treating patients with skin cancer or solid tumors metastatic to the skin
• Topical imiquimod compared with surgery in treating patients with basal cell skin cancer
• Study of talabostat and cisplatin in advanced melanoma
• FDA warns of illegal home medical test kits
• Tetracycline in preventing skin rash in patients who are receiving drugs such as gefitinib and cetuximab for cancer
• To study the effects of CD25 and low dose cyclosporin in the treatment of active psoriasis vulgaris
• Fluocinonide 0.1% cream approved for plaque-type psoriasis
• Characterizing serum protein patterns in selected skin diseases
• Conditioning, the placebo effect, and psoriasis
• Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient cream
  by Debra Breneman
• Second-generation pulsed light system receives FDA approval
• Examination of clinical and laboratory abnormalities in patients with defective DNA repair: xeroderma pigmentosum, Cockayne syndrome, or trichothiodystrophy
• Genetic analysis of familial keloids
• An investigational vaccine in reducing the incidence of anogenital warts in young men
• In contrast with PAR-2 mediated nociception and hyperalgesia, melanosome transfer does not involve N-methyl-D-aspartate receptors
  by M.R. Namazi
• Evaluation of subcision as a treatment for cutaneous striae
  by Pilar Luis-Montoya
• Hydrocortisone butyrate 0.1% cream in the treatment of chronic dermatitis
• Infliximab to treat dermatomyositis and polymyositis
• To study the use of humanized CD25 in preventing the relapse of psoriasis vulgaris
• Study of oral zileuton in the treatment of moderate to severe facial acne vulgaris
• The potential of interleukin 12 inhibition in the treatment of psoriasis
  by David Rosmarin
• Clofazimine as elective treatment for granulomatous cheilitis
  by Lourdes Rodriguez Fdez.-Freire
• Oral acyclovir for neonatal HSV disease of the skin, eyes, and mouth
• Study of talabostat in advanced melanoma
• Alopecia areata registry
• Treatment and prophylaxis of seborrheic dermatitis of the scalp with antipityrosporal 1% ciclopirox shampoo
• Celecoxib in preventing skin cancer
• Photodynamic therapy in treating patients with lymphoma or chronic lymphocytic leukemia
• FDA approves vaccinia-specific IgG injection for complications of smallpox vaccination
• ZD1839 for recurrent or metastatic squamous cell carcinoma of the skin
• Evaluation and treatment of patients with dermatologic diseases
• Preliminary testing of new treatment for chronic leg wounds
• New Drug Application submitted for dalbavancin for treatment of skin infections
• Bevacizumab to treat Kaposi's sarcoma in HIV-positive and HIV-negative patients
• Merkel cell carcinoma in a patient with autoimmune hepatitis
  by Joseph Lillis
• Photodynamic therapy in treating patients with skin cancer
• Skin response to sunlight
• Copper histidine therapy for Menkes diseases
• The ABCDEs of melanoma: an evolving concept
  by David Polsky
• The effect of lidocaine and adrenaline on the viability of injected adipose tissue—an experimental study in nude mice
  by Oren Shoshani
• Isotretinoin in acne vulgaris: a prospective analysis of 160 cases from Kuwait
  by Nawaf Al-Mutairi
• T4N5 liposomal lotion in preventing the recurrence of nonmelanoma skin cancer in patients who have undergone a kidney transplant
• Serum protein patterns in participants with mycosis fungoides/cutaneous T-cell lymphoma, psoriasis, or normal skin
• Topical aminolevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study
• FDA warns of Zyprexa® and Zyrtec® substitution errors
• Therapeutic decision making in the therapy of actinic keratoses
  by James M. Spencer
• The successful use of etanercept in combination therapy for treatment of acrodermatitis continua of Hallopeau
  by Kimberly Kazinski
• Centocor files sBLA for infliximab
• Bioengineered skin and wound healing
• Photodynamic therapy in treating patients with skin cancer
• Study of skin tumors in tuberous sclerosis
• Phase II randomized bilateral comparison of topical Targretin® gel 1% in alopecia areata
• The use of terbinafine in the treatment of onychomycosis in adults and special populations: a review of the evidence
  by Aditya K. Gupta
• Furuncular myiasis secondary to Dermatobia hominis
  by Joshua E. Lane
• Comparison of telavancin and vancomycin for complicated skin and skin structure infections with a focus on methicillin-resistant staphylococcus aureus